202 related articles for article (PubMed ID: 7444368)
1. Cysteamine-induced duodenal ulcer and acid secretion in the rat.
Kirkegaard P; Poulsen SS; Loud FB; Halse C; Christiansen J
Scand J Gastroenterol; 1980; 15(5):621-4. PubMed ID: 7444368
[TBL] [Abstract][Full Text] [Related]
2. The effect of cysteamine on the Brunner gland secretion in the rat.
Kirkegaard P; Poulsen SS; Halse C; Loud FB; Skov Olsen P; Christiansen J
Scand J Gastroenterol; 1981; 16(1):93-6. PubMed ID: 7233083
[TBL] [Abstract][Full Text] [Related]
3. Mucosal enzyme activities, with special reference to enzymes implicated in bicarbonate secretion, in the duodenum of rats with cysteamine-induced ulcers.
Stiel D; Murray DJ; Peters TJ
Clin Sci (Lond); 1983 Mar; 64(3):341-7. PubMed ID: 6822066
[TBL] [Abstract][Full Text] [Related]
4. The role of gastric and duodenal pH in the cysteamine-induced duodenal ulcer in the rat.
Kusterer K; Rohr G; Herrmann W; Piplack C; Schwedes U; Usadel KH; Szabo S
Acta Physiol Hung; 1989; 73(2-3):247-50. PubMed ID: 2596314
[TBL] [Abstract][Full Text] [Related]
5. Brunner's glands of the rat during cysteamine ulceration.
Poulsen SS; Kirkegaard P; Skov Olsen P; Christiansen J
Scand J Gastroenterol; 1981; 16(4):459-64. PubMed ID: 7323682
[TBL] [Abstract][Full Text] [Related]
6. The effect of verapamil on cysteamine-induced duodenal ulcer in the rat.
Lee CK; Yim DS; Kim WH
J Korean Med Sci; 1987 Dec; 2(4):247-53. PubMed ID: 3268182
[TBL] [Abstract][Full Text] [Related]
7. Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer.
Szabo S; Pihan G; Gallagher GT; Brown A
Scand J Gastroenterol Suppl; 1984; 92():106-11. PubMed ID: 6588493
[TBL] [Abstract][Full Text] [Related]
8. Diversion of bile and pancreatic secretion in the rat and its effect on cysteamine-induced duodenal and peptic ulcer development under maximal acid secretion.
Clémençon GH; Fehr HF; Finger J
Scand J Gastroenterol Suppl; 1984; 92():112-5. PubMed ID: 6588494
[TBL] [Abstract][Full Text] [Related]
9. Effect of antisecretory agents and vagotomy on healing of "chronic" cysteamine-induced duodenal ulcers in rats.
Poulsen SS; Raaberg L; Therkelsen K; Skov Olsen P; Kirkegaard P
Dig Dis Sci; 1986 Jul; 31(7):753-9. PubMed ID: 3720471
[TBL] [Abstract][Full Text] [Related]
10. Role of delayed gastric emptying in the pathogenesis of cysteamine-induced duodenal ulcer in the rat.
Poulsen SS; Kirkegaard P; Olsen PS; Jensen KK; Christiansen J
Scand J Gastroenterol; 1982 Apr; 17(3):325-30. PubMed ID: 7134859
[TBL] [Abstract][Full Text] [Related]
11. Secretory changes associated with chemically-induced duodenal ulceration: simultaneous measurements of acid, pepsin, base and pancreatic enzymes in rats with chronic gastric fistula.
Gallagher GT; Szabo S
Digestion; 1984; 29(2):73-84. PubMed ID: 6203801
[TBL] [Abstract][Full Text] [Related]
12. [An experimental study of adrenalin-stimulated gastric acid secretion and gastrin secretion in rats of cysteamine-induced duodenal ulcer].
Koga S; Kashiwagi H; Aoki T
Nihon Shokakibyo Gakkai Zasshi; 1992 Mar; 89(3):580-7. PubMed ID: 1578802
[TBL] [Abstract][Full Text] [Related]
13. Biliary and pancreatic secretions influence experimental duodenal ulcer without affecting gastric secretion in the rat.
Pihan G; Gallagher GT; Szabo S
Dig Dis Sci; 1985 Mar; 30(3):240-6. PubMed ID: 3918841
[TBL] [Abstract][Full Text] [Related]
14. Effect of dopamine-related drugs on duodenal ulcer induced by cysteamine or propionitrile: prevention and aggravation may not be mediated by gastrointestinal secretory changes in the rat.
Gallagher G; Brown A; Szabo S
J Pharmacol Exp Ther; 1987 Mar; 240(3):883-9. PubMed ID: 3559980
[TBL] [Abstract][Full Text] [Related]
15. Duodenal ulcerogens cysteamine and propionitrile decrease duodenal neutralization of acid in the rat.
Adler RS; Gallagher GT; Szabo S
Dig Dis Sci; 1983 Aug; 28(8):716-23. PubMed ID: 6872804
[TBL] [Abstract][Full Text] [Related]
16. Cysteamine-induced duodenal ulcer and the hepatoduodenal branch of the vagus nerve.
Kato K; Watanabe T; Itoh M; Yoshida S; Hoshino N; Itoh K; Sugimura F; Iwasaki A; Matsuo Y; Sawai H
Gastroenterol Jpn; 1990 Jun; 25(3):314-9. PubMed ID: 1972686
[TBL] [Abstract][Full Text] [Related]
17. 4-Methoxyphenyl 4-(3,4,5-trimethoxybenzyl)-1-piperazineacetate monofumarate monohydrate (KB-5492), a new anti-ulcer agent with a selective affinity for the sigma receptor, prevents cysteamine-induced duodenal ulcers in rats by a mechanism different from that of cimetidine.
Morimoto Y; Shimohara K; Tanaka K; Hara H; Sukamoto T
Jpn J Pharmacol; 1994 Mar; 64(3):221-4. PubMed ID: 8022123
[TBL] [Abstract][Full Text] [Related]
18. Role of local motility changes in the pathogenesis of duodenal ulcers induced by cysteamine in rats.
Takeuchi K; Nishiwaki H; Okabe S
Dig Dis Sci; 1987 Mar; 32(3):295-304. PubMed ID: 3816483
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers.
Kirkegaard P; Olsen PS; Poulsen SS; Nexø E
Gastroenterology; 1983 Dec; 85(6):1277-83. PubMed ID: 6605273
[TBL] [Abstract][Full Text] [Related]
20. Effects of fundic vagotomy and cholinergic replacement on pentagastrin dose responsive gastric acid and pepsin secretion in man.
Hirschowitz BI; Helman CA
Gut; 1982 Aug; 23(8):675-82. PubMed ID: 6807759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
